All filters
Slidesets
Access to Key Populations - Mojca Maticic, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Access to Quality Assured (WHO Prequalified) Generic Medicines in the Region - Liudmyla Maista
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
07_Boeva
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
The Prevalence of Mutations of the Hepatitis C Virus, Associated with Drug Resistance to Inhibitors of Protein NS5A Among Patients of the Republic of Belarus - Elena Gasich
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Virological Efficacy of First-Line Regimens, Resistance Profile and Factors Influencing Adherence to ART in Clinical Practice in Ukraine - Tetiana Kyrychenko
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Switching to Second Line HIV Therapy - Pavel Khaykin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
PrEP and STI Testing in CEE: What are the Barriers, What Works? - Miłosz Parczewski, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Epidemiology of HIV in the Baltic Countries (Estonia, Latvia, Lithuania) - Saulius Čaplinskas
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Integrated Testing for HIV, Hepatitis, and STIs - Dorthe Raben, MSc
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
The New Tendencies in HIV and HCV Epidemics in Central Region of Ukraine - Tetiana Koval
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Management of Hepatitis C in Primary Healthcare in the Country of Georgia - Akaki Abutidze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
HCV Prevalence and Associated Factors Among People who Inject Drugs (PWID): Baseline Results of Georgian PWID Cohort Study - Ketevan Shermadini
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Outcomes for Hepatitis B Vaccination Among HIV-Infected Adults in Georgia - Shorena Dvali
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Diversity of HIV-1 Subtypes in Russia 2009-2019 - Konstantin Gromov
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Epidemiology of Hepatitis B Viral Infection in the Republic of Belarus - Viktar Mitsura
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
High Level of Integrase Strand Transfer Inhibitors Drug Resistance Mutations in INSTIs Failed HIV-1 CRF06_cpx Infected Patients in Estonia - Merit Pauskar
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Implementation of the State Program on Elimination of Viral Hepatitis C in Ukraine: Achievements and Challenges - Kristyna Pronyuk
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Vaccinations for HIV Patients: Which Vaccinations When and How? - Carolynne Schwarze-Zander, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
HIV/HCV Co-Infection: Influence on Risk for Cancer and Cardiovascular Events, and Impact of Successful HCV Cure - Ligita Jancoriene, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Meeting
APACC 2019
Slidesets
Transitioning from International to Domestic Funding: Experiences in the Asia Pacific- Ravipa Vannakit, RN, MSc
Presented at:
APACC 2019
Slidesets
Transitioning to Sustainable Mechanisms for Priority Public Health Programmes in The Western Pacific- Naoko Ishikawa, MD, MSc, PhD
Presented at:
APACC 2019